EMBO Molecular Medicine

Publisher： John Wiley & Sons Inc

Founded in： 2008

Total resources： 50

E-ISSN： 1757-4684

ISSN： 1757-4676

Subject： F0 Economics

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

EMBO Molecular Medicine

Menu

Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next‐generation human artificial chromosomes for Duchenne muscular dystrophy

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 254-275

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Loss of RASGRP1 in humans impairs T‐cell expansion leading to Epstein‐Barr virus susceptibility

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 188-199

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 219-238

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 200-218

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 139-150

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Chimeric Pneumoviridae fusion proteins as immunogens to induce cross‐neutralizing antibody responses

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 175-187

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 239-253

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 276-293

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 294-308

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Compounds producing an effective combinatorial regimen for disruption of HIV‐1 latency

EMBO Molecular Medicine , Vol. 10, Iss. 2, 2018-02 , pp. 160-174

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 ... 13 Next Display item(s) per page Total 130 item(s)